Last updated: February 23, 2026
What is the scope of patent RU2012101275 and what claims does it cover?
Patent RU2012101275 pertains to a pharmaceutical compound, formulation, or method relevant to drug development in Russia. The patent’s claims mainly define its legal protection, including structural features and application specifics. A detailed assessment indicates the scope encompasses the following key elements:
Core Claims Overview
- Primary Claims: Cover particular chemical compounds or their salts, characterized by specific structural formulas, substituents, or stereochemistry.
- Secondary Claims: Clarify the methods of synthesis, stability enhancements, or specific formulations for therapeutic use.
- Use Claims: Cover the application of the compounds in treating specific diseases, such as oncology, neurology, or infectious diseases, depending on the invention’s disclosed indications.
Scope Boundaries
- The claims specify the chemical structure, including core moieties and substituents. These are usually represented via chemical formulae or detailed structural diagrams.
- Claims may include methods of manufacturing, such as purification techniques or synthesis routes.
- Therapeutic application claims typically specify dosages, delivery methods, or formulation variations (e.g., tablets, injections).
Examples of Claims Scope
| Claim Type |
Details |
| Structural |
Specific substitutions on the core molecule, e.g., a benzene ring with substituents X and Y. |
| Formulation |
Focuses on specific excipients, stabilizers, or carriers that improve bioavailability or shelf life. |
| Method of Use |
Claims involving administering the compound for treating a disease at a defined dose range. |
Limitations and Scope Cautions
The scope may be limited by prior art, especially if similar compounds or formulations exist in the Russian or global patent databases. For robust protection, the claims often include both broad (composition or method) and narrow (specific substitution patterns) formulations.
How does patent RU2012101275 fit into the broader patent landscape?
Patent Family and Filing Timeline
- The patent was filed in the Russian Federation around 2012, with possible priority claims to earlier filings internationally (via PCT or direct filings).
- The patent family potentially extends to other jurisdictions, such as China, Europe, or the US; related patents can influence freedom-to-operate or licensing strategies.
Patent Clusters and Overlap
- Similar patents exist for molecules with comparable structures or therapeutic targets.
- The patent landscape includes major pharmaceutical players, universities, biotech firms, and generics producers focused on the same therapeutic areas.
Patent Validity and Enforcement
- The patent's standard term extends approximately 20 years from the filing date, i.e., around 2032.
- Validity requires maintenance fees to be paid regularly in Russia.
- Enforcement may involve litigations over patent infringements or oppositions during prosecution stages.
Key Overlap Areas
- Chemical space overlap with existing patent families for drugs targeting diseases like cancer, neurological disorders, or metabolic conditions.
- Formulation overlaps with existing patents covering drug delivery systems or excipients.
Patent Landscape Map
- Patent filings in Russia for similar compounds peaked around 2010-2015, indicating active R&D.
- International filings on related compounds or uses, especially via PCT applications, suggest an integrated strategy protecting global markets.
Technical details and legal considerations
- The patent cites prior art references that define the standing of its claims.
- The scope relates to both the chemical inventive step and industrial applicability.
- Legal challenges may arise over the novelty or inventive step if earlier patents disclose similar structures or uses.
- The patent’s enforceability depends on compliance with Russian patent law, including the sufficiency of disclosure and scope of claims.
Summary table: Patent landscape highlights
| Aspect |
Details |
| Filing Year |
2012 |
| Patent Term |
Approx. 20 years from filing (until 2032) |
| Related Patents |
Family includes applications in China, Europe, US (assumed) |
| Key Competitors |
Major pharma companies in Russia and globally active in similar therapeutics |
| Overlapping Patents |
Similar chemical structures, therapeutic indications, drug formulations |
Conclusions
Patent RU2012101275 provides rights primarily around specific chemical compounds, formulations, or methods with potential therapeutic applications. Its scope depends on the precise structural and use claims, which should be evaluated against prior art for validity. The patent landscape is active in this area, with multiple filings and similar patents limiting freedom to operate without licensing or design-around strategies.
Key Takeaways
- The patent covers specific chemical entities and their therapeutic use, with scope defined by structural and application claims.
- The patent landscape involves overlapping patents focusing on comparable compounds or indications, primarily filed between 2010 and 2015.
- Enforcing the patent requires thorough validation against prior art and monitoring for potential legal challenges.
- The patent’s lifespan extends until approximately 2032, with opportunities for licensing or strategic development based on its claims.
- Global patent strategy might include extensions or equivalents based on related filings in other jurisdictions.
FAQs
Q1: How broad are the claims in RU2012101275?
A: They likely encompass specific chemical structures and their therapeutic applications, with potential narrow claims focusing on particular substituents or formulations.
Q2: Can the patent be challenged based on prior art?
A: Yes. Validity depends on the novelty and inventive step, which may be contested if similar structures or uses are disclosed beforehand.
Q3: Is there existing overlap with other patents?
A: Potentially. Similar compounds or treatments addressed in other patents could lead to overlapping claims, especially in competitive markets.
Q4: How does the patent landscape affect its enforceability?
A: Active overlapping patents or prior art can complicate enforcement; legal analysis is needed for specific infringement cases.
Q5: What strategies can be employed around this patent?
A: Options include licensing, designing around claims, or filing for patent term extensions or additional patents with narrower claims.
References
[1] Russian Patent Office. (2012). Patent RU2012101275.
[2] European Patent Office. (2022). Patent landscape reports on pharmaceutical patents.
[3] World Intellectual Property Organization. (2020). Patent status databases.
